Diagnostic Performance of Noninvasive Tests for Advanced Hepatic Fibrosis in Young Age Population
- Authors
- Kim, Mimi; Yoon, Eileen Laurel; Lee, Jonghyun; Cho, Seon; Lee, Chul-Min; Kang, Bo Kyeong; Park, Huiyul; Jun, Dae Won; Nah, Eun-Hee
- Issue Date
- Jul-2023
- Publisher
- W.B. Saunders
- Keywords
- Nonalcoholic Fatty Liver Disease; Aspartate Aminotransferase-to-Platelet Ratio Index; Noninvasive Test; He-patic Fibrosis; Advanced Hepatic Fibrosis
- Citation
- Clinical Gastroenterology and Hepatology, v.21, no.7, pp.1831 - 1840.e12
- Indexed
- SCIE
SCOPUS
- Journal Title
- Clinical Gastroenterology and Hepatology
- Volume
- 21
- Number
- 7
- Start Page
- 1831
- End Page
- 1840.e12
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/192073
- DOI
- 10.1016/j.cgh.2022.10.020
- ISSN
- 1542-3565
- Abstract
- Background & Aims: Most noninvasive tests (NITs) for hepatic fibrosis are designed for middle-aged patients with chronic liver disease. We compared the diagnostic performance of major NITs (aspartate aminotransferase–to-platelet ratio index [APRI], Fibrosis-4 index, and nonalcoholic fatty liver disease fibrosis score) for a community-based cohort. Methods: This cross-sectional study analyzed 8775 participants who underwent magnetic resonance elastography at community health check-up centers. Advanced hepatic fibrosis (≥F3) was defined by magnetic resonance elastography thresholds of 3.6 kPa. The diagnostic performance of 3 NITs was evaluated according to the etiology of liver disease, sex, metabolic syndrome, obesity, and increased aminotransferase levels in 4 age groups. Results: The APRI generally showed the best area under the receiver operating characteristic curve in patients aged 45 years or younger, and it was statistically significant in patients with chronic viral hepatitis and alcoholic fatty liver disease (P < .043). The best APRI cut-off value for detecting advanced hepatic fibrosis was 0.4, with a sensitivity and specificity of 75.8% and 73.5%, respectively, in the community-based cohort. The APRI showed balanced sensitivity and specificity across all age groups, whereas the other metrics showed low sensitivity in those aged <45 and low specificity in those >65 years. Conclusions: The APRI showed better sensitivity and negative predictive value than the Fibrosis-4 index and the nonalcoholic fatty liver disease fibrosis score in community-based populations with mixed etiology, and, thus, can be performed as the primary test in young adults (age, ≤45 y).
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 1. Journal Articles
- 서울 의과대학 > 서울 영상의학교실 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.